Glac Biotech (Bioflag Group), Taiwan, is a dedicated, innovative and leading probiotic/postbiotic company. We not only focus on the nutraceutical and functional food markets, but specialize in developing, manufacturing and marketing advanced probiotic/postbiotic research and applications as well. Since the establishment in 2008, glac Biotech has kept developing novel probiotics/postbiotics to fit the trend of healthcare markets. With advanced R&D team, our core technologies include probiotic strain development capability, functional screening platforms, high quality mass production, and not to mention our patented micro-encapsulation and freeze-drying technologies to stabilize live bacteria. We proudly position ourselves as probiotic strain bank with more than 1,000 probiotic strains and establish functional screening platforms to complete numerous in vitro, animal and human clinical studies. The major product lines of glac Biotech include clinically proven probiotic blend series, PRONULIFE, and innovative Totipro postbiotic series as ingredients for supplements and functional foods. These clinically tested probiotics/postbiotics provide different health benefits, focusing on sports performance, oral health, gastric and bowel health, immunity and allergy relief, kidney health, vaginal care, weight management, and uric acid control. Liver protection, blood sugar control, and applications in infants and young children are also in our pipeline. With wide range applications of our functional probiotic/postbiotic ingredients, we firmly believe that they will definitely be your margin generator and a valuable addition to your product portfolio. Professional contract manufacturing services for your private label are offered as well. Please visit us at: Vitafoods Europe (D170I), May 10-12, 2022 https://youtu.be/EvTLZx41hNc Should you have any further question or inquiry, please contact: Michael Hsiao Email: michael.hsiao@bioflag.com.tw Whatsapp: +886-939958081